Ernexa Therapeutics (ERNAW) Treasury Shares (2010 - 2022)
Ernexa Therapeutics' (ERNAW) quarterly Treasury Shares came in at $456000.0 in Q4 2020, little changed YoY from $456000.0 in Q1 2020, and little changed on a QoQ basis from $456000.0 in Q3 2020.
Analysis
Ernexa Therapeutics (ERNAW) Treasury Shares (2010 - 2022) Analysis & Trends
Ernexa Therapeutics (ERNAW) has 11 years of Treasury Shares data on file, last reported at $456000.0 in Q4 2020.
- Quarterly Treasury Shares changed 0.0% year-over-year to $456000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $456000.0 (changed 0.0% YoY) and the FY2020 annual result came in at $456000.0, changed 0.0% from the prior year.
- Treasury Shares steadied at $456000.0 in Q4 2020, from $456000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.3 million in Q1 2022 to a low of $500.0 in Q1 2025.
- A 5-year average of $156576.9 and a median of $4000.0 in 2022 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 0.0% in 2016, down 0.0% in 2016.
- Tracing ERNAW's Treasury Shares over 5 years: stood at $456000.0 in 2016, then changed by 0.0% to $456000.0 in 2017, then changed by 0.0% to $456000.0 in 2018, then changed by 0.0% to $456000.0 in 2019, then changed by 0.0% to $456000.0 in 2020.
- The last three Treasury Shares figures came in at $456000.0 (Q4 2020), $456000.0 (Q3 2020), and $456000.0 (Q1 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Ernexa Therapeutics | 67,312.70 | 67,312.70 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 914.00 |
| Mar 31, 2022 | 914.00 |
| Dec 31, 2020 | 10,000.00 |
| Dec 31, 2020 | 10,000.00 |
| Dec 31, 2020 | 456,000.00 |
| Dec 31, 2020 | 456,000.00 |
| Sep 30, 2020 | 456,000.00 |
| Sep 30, 2020 | 10,000.00 |
| Sep 30, 2020 | 10,000.00 |
| Sep 30, 2020 | 456,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Mar 31, 2020 | 456,000.00 |
| Mar 31, 2020 | 456,000.00 |
| Dec 31, 2019 | 456,000.00 |
| Dec 31, 2019 | 456,000.00 |
| Dec 31, 2019 | 10,000.00 |
| Dec 31, 2019 | 10,000.00 |
| Sep 30, 2019 | 10,000.00 |
| Sep 30, 2019 | 456,000.00 |